Announced Thu, 2 Jul · 16:21 IST
US-FDA inspection at Bengaluru facility ends with one observation
Business Updates View source PDF
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹1676.20
prior close
₹1707.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.9-1.9-2.2-2.3-0.8-2.6-3.8-3.1-2.6-1.7-1.6———
Up moveDown movePending
AI summary
US-FDA conducted a routine cGMP inspection at OneSource Specialty Pharma's Sterile Product Division facility in Bengaluru from June 22 to June 30, 2026. The inspection ended with one observation, which the company will respond to within the stipulated timeframe. No details on the nature of the observation were shared.
Likely market impact
A single observation is usually treated as minor, but markets often react cautiously until the company's response is accepted by FDA.